As the authorized distributor of QIAGEN, it was both an honor and a pleasure for us to attend the congress once again alongside the QIAGEN team. Throughout the three-day event, we closely followed the latest scientific developments and had the opportunity to present our advanced technology solutions to esteemed professors, specialists, and colleagues.

At the congress, QIAGEN’s QIAcuity Digital PCR technologies attracted significant attention thanks to their outstanding performance in precision and accuracy. In addition, the newly introduced Franklin software, added to QIAGEN’s portfolio through a recent partnership, stood out as one of the key innovations showcased this year.

On 28 November, within the scope of the congress, an insightful satellite symposium titled “QIAGEN Digital Insights” was held, moderated by Assoc. Prof. Ahmet Cevdet Ceylan and presented by Ruth Burton from QIAGEN. The session offered a comprehensive overview of clinical applications and highlighted how the Franklin digital data analytics platform contributes to clinical decision-support processes—providing valuable perspectives for both us and all participants.

The strong interest shown in our booth, the fruitful discussions we held, and the new professional connections we established throughout the event brought great motivation and energy to our entire team. We extend our heartfelt appreciation to the Associatıon of Medical Genetics, the organizing committee, all speakers, the QIAGEN family, and our esteemed professors for their contributions to this meaningful gathering.

We look forward to many more scientific meetings together!

Throughout the congress, we had the chance to present our innovative solutions, share up-to-date approaches to laboratory practices, and engage in productive discussions with many centers.

We sincerely thank all participants who visited our booth and showed interest in our work at this event, where we aim to strengthen scientific collaboration and contribute to advancements in diagnostics.

We would also like to thank all institutions and academicians who contributed to the organization, and we look forward to continuing to shape the future of clinical microbiology together.

We were delighted to participate in the 34th National Pathology Congress, held on 12–16 November 2025 at Pine Beach Hotel, Antalya, as Qiagen’s authorized distributor and in collaboration with Qiagen.

Throughout the congress, we were present at the Qiagen booth, where we had the opportunity to meet esteemed professors and specialists from the field, and to share Qiagen’s innovative solutions with participants. We also attended Qiagen’s presentation in the scientific program, gaining deeper insights into the current applications of our product portfolio in pathology, molecular diagnostics, NGS workflows, and bioinformatics analysis processes.

Among the key scientific and technological topics highlighted during the congress were major diagnostic areas such as cytopathology, bone and soft tissue pathology, pulmonary pathology, and uropathology, as well as molecular pathology, NGS applications, genomic instability, biomarker-based approaches, and emerging markers in immunohistochemistry. In addition, sessions on digital pathology, AI-assisted image analytics, deep learning–based decision-support systems, and bioinformatics data analysis and reporting provided highly valuable insights.

As the Labgen team, we conducted one-on-one meetings with visitors, evaluated user experiences and field requirements, and addressed questions particularly related to NGS workflows, bioinformatics data interpretation, and IHC panel optimization. We also attended sessions presented by distinguished experts, gaining numerous new perspectives that will contribute directly to our work.

We sincerely thank the Turkish Federation of Pathology Societies, all speakers, the Qiagen team, and all esteemed professors for this productive organization.

With the knowledge we gained and the new connections we established, we will continue to provide stronger, more up-to-date, and more effective solutions in the field of laboratory diagnostics.

Kind regards,
Labgen

Representatives from several branches—primarily Adult and Pediatric Infectious Diseases, Dermatology, and Rheumatology—participated in the event. The presentation covered the clinical use of the Quantiferon test, its scientific foundation, application advantages, and result interpretation processes in detail.

The Quantiferon TB Gold Plus test offers a more reliable solution compared to classical methods by providing high specificity and sensitivity in the diagnosis of latent tuberculosis infection.

The main goal of the event was to encourage the more effective use of the test in clinical practice and to build shared awareness among healthcare professionals regarding diagnostic processes.

As Labgen, we will continue to strengthen our collaborations in the healthcare sector and contribute to diagnostic processes with innovative solutions.

HGMD (Human Gene Mutation Database): A database that compiles mutations found in human genes and their associations with diseases. It is a crucial resource for the research, diagnosis, and treatment of genetic disorders. HGMD helps scientists, clinical geneticists, and researchers understand the impact of genetic variations on human health.

HSMD (Human Somatic Mutation Database): A database that collects and analyzes human somatic mutations. It is an essential resource for scientists studying the genetic basis of cancer and other diseases. Somatic mutations occur in body cells and are not inherited, playing a critical role in the development of conditions such as cancer.